Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice

Image: Phys.org
ad slot · in-content video 16:9
Coverage
More coverage
- In people with type 1 diabetes, the immune system mistakenly identifies insulin-producing cells in the pancreas as foreign and attacks them, leaving the body unable to properly regulate blood sugar. While insulin therapy helps manage the disease, it does not stop the underlying immune attack.